Abstract
Background
Infective endocarditis (IE) is a fatal cardiovascular disease with varied clinical manifestations but rapid progression. A series of existing risk models helped identify IE patients with high risk, but the imperfect predictive performance and limited application called for better predictive systems.
Methods
The single-centered, retrospective observational study applied four machine learning methods for predictive model construction: LASSO logistic regression, random forest (RF), support vector machine (SVM), and k-nearest neighbors (KNN). A 10-fold cross-validated area under the receiver operating characteristic curve (AUC-ROC) was used for performance evaluation.
Results
A total of 1705 patients with IE were enrolled in the study, with 119 in-hospital deaths and 178 deaths after 6-month follow-up. RF achieved the highest AUC-ROCs for in-hospital and six-month mortality prediction (in-hospital: 0.83, 6-month: 0.85). RF was also applied to assess variable importance. The following variables were selected by RF as top important predictors for both in-hospital and six-month mortality prediction: total bilirubin, N-terminal pro-B-type natriuretic peptide, albumin, diastolic blood pressure, fasting blood glucose, uric acid, and age.
Conclusions
A risk model with machine learning approach was integrated in purpose of prognosis prediction in IE patients, helping rapid risk stratification and in-time management clinically.
Clinical trial number
Not applicable.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer




